GGrantIndex
Sort

166,118 grants matching stem cells

Comprehensive NeuroHIV Center

$1,499,999
Kamel Khalili · Temple Univ Of The Commonwealth · P30 · FY2022 · MH

IGF::OT::IGF TP508 MITIGATES RADIOTHERAPY-INDUCED TISSUE DAMAGE - PERIOD OF PERF

$1,499,927
Laurie Sower · Chrysalis Biotherapeutics, Inc. · N44 · FY2013 · CA

RECODE: Rules-based Morphogenesis of Brain Organoids through Synthetic Gene Circuits

$1,499,912
Jonathan M Brunger · Vanderbilt University · · FY2020 · ENG

Center of All-Solid-State Batteries for a Clean Energy Society

$1,499,867
Leon L Shaw · Illinois Institute Of Technology · · FY2023 · O/D

Study of hereditary prostate cancer and human artificial chromosomes

$1,499,749
Vladimir Larionov · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Developmental Neurotoxicity Health Effects Innovation Research Program

$1,499,628
Christopher Anthony McPherson · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES

Comprehensive Sickle Cell Center

$1,499,547
Clinton H. Joiner · Cincinnati Childrens Hosp Med Ctr · U54 · FY2009 · HL

SMALL BUSINESS INNOVATION RESEARCH PROGRAM (SBIR)

$1,499,547
Hal Crosswell · Kiyatec, Inc. · N43 · FY2016 · CA

Improved Diagnosis and Treatment of Cushing's Disease

$1,499,462
Prashant Chittiboina · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS

IGF::OT::IGF: SBIR PHASE II, TOPIC 326: DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS

$1,499,399
David Eavarone · Siamab Therapeutics, Inc. · N44 · FY2016 · CA

EDGE: Establishing functional genomics in Hydra to study stem cells and regeneration

$1,499,305
Celina Juliano · University Of California-Davis · · FY2018 · BIO

Preclinical and Clinical Studies in Gene Therapy for Sickle Cell Disease

$1,499,275
John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

Isolation, characterization, and transplantation of candidate stem cells

$1,499,275
John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

Development of a novel oral brain penetrant therapeutic for ALS disease

$1,499,212
Glenn Larsen · Aquinnah Pharmaceuticals, Inc. · R44 · FY2025 · NS

Engineering a human brain organoid-based platform to study neurotropic viruses

$1,499,160
Guo-Li Ming · University Of Pennsylvania · U19 · FY2021 · AI

Control of Myogenesis and Regulation of MyoD Post-Transcriptional Modifications

$1,499,157
Vittorio Sartorelli · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR

ETIB Clinical Research Core

$1,498,841
Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2021 · CA

STEM CELLS ALONE OR IN POLYETHYLENE GLYCOL-FIBRIN MATRICES TO PREVENT CONTRATCION AND ENHANCE HEALING IN THIRD DEGREE BURNS

$1,498,820
University Of Miami · · FY2014 · Department of the Army

Defining and Manipulating Epigenomic Regulators in Endogenous Systems

$1,498,670
Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

MFB: Deep-Learning Enabled Structure Prediction and Design of Protein-DNA Assemblies

$1,498,460
David Baker · University Of Washington · · FY2022 · MPS

Cartilage Regeneration with Tunable Inflammation Resistance

$1,498,253
Bradley T Estes · Cytex Therapeutics Inc. · R44 · FY2020 · AG

Emory Specialized Center of Research Excellence (SCORE) on Sex Differences

$1,498,219
Ighovwerha Ofotokun · Emory University · U54 · FY2019 · AG

Tri-Regional Information Technology (Tri-IT) Program

$1,498,204
Ladonna Morris · Florida State College At Jacksonville · · FY2008 · EDU

Retinal Ganglion Cell Replacement in Optic Neuropathies

$1,498,013
Jeffrey L Goldberg · Stanford University · U24 · FY2018 · EY

CAREER: Mechanisms Underlying Temporal Integration of BMP Signaling in Cell Fate Decisions

$1,497,932
Idse J Heemskerk · Regents Of The University Of Michigan - Ann Arbor · · FY2024 · BIO